» Articles » PMID: 23746414

Microbiology of Bacteria Causing Recurrent Acute Otitis Media (AOM) and AOM Treatment Failure in Young Children in Spain: Shifting Pathogens in the Post-pneumococcal Conjugate Vaccination Era

Abstract

Objective: To prospectively identify the bacterial aetiology and antimicrobial susceptibility of problematic (recurrent and treatment failure) acute otitis media in Spanish children several years after the introduction of 7-valent pneumococcal conjugate vaccine.

Methods: Tympanocentesis or careful sampling of spontaneous otorrhoea was performed on children aged 3 to <36 months with recurrent acute otitis media, acute otitis media treatment failure or unresolved acute otitis media.

Results: 105 acute otitis media episodes (77 sampled by tympanocentesis, 28 otorrhoea samples) were evaluated: 46 recurrent, 35 treatment failures, 24 unresolved acute otitis media. 74 episodes (70.4%) had at least one bacterium identified on culture: Streptococcus pneumoniae was identified in 21 episodes, Haemophilus influenzae (all non-typeable) in 44, Streptococcus pyogenes in 2, Moraxella catarrhalis in 2. No statistically significant difference in bacterial aetiology by episode type was detected. Non-typeable H. influenzae was the most commonly isolated pathogen in all acute otitis media types and in all age sub-groups. Forty percent of S. pneumoniae isolates were multi-drug resistant. Pneumococcal serotype 19A was the most frequently identified serotype (7/21 episodes). Multi-drug resistance was found in 56% of 19A isolates. Of non-typeable H. influenzae isolates, 15% were ampicillin resistant and 13% were amoxicillin/clavulanate resistant. S. pneumoniae and non-typeable H. influenzae DNA were each detected in 57% of samples culture negative for these pathogens, including 12 co-infections.

Conclusion: Combining culture and polymerase chain reaction results, H. influenzae and S. pneumoniae may be implicated in 70% and 43% of clinically problematic bacterial acute otitis media episodes, respectively. The impact of new vaccines to prevent both S. pneumoniae and non-typeable H. influenzae acute otitis media may be substantial in this population and is worth investigating.

Citing Articles

Clinical and economic burden of acute otitis media caused by Streptococcus pneumoniae in European children, after widespread use of PCVs-A systematic literature review of published evidence.

Ricci Conesa H, Skroder H, Norton N, Bencina G, Tsoumani E PLoS One. 2024; 19(4):e0297098.

PMID: 38564583 PMC: 10986968. DOI: 10.1371/journal.pone.0297098.


Oral and middle ear delivery of otitis media standard of care antibiotics, but not biofilm-targeted antibodies, alter chinchilla nasopharyngeal and fecal microbiomes.

Duff A, Jurcisek J, Kurbatfinski N, Chiang T, Goodman S, Bakaletz L NPJ Biofilms Microbiomes. 2024; 10(1):10.

PMID: 38310144 PMC: 10838340. DOI: 10.1038/s41522-024-00481-0.


First global report about the prevalence of multi-drug resistant Haemophilus influenzae: a systematic review and meta-analysis.

Abavisani M, Keikha M, Karbalaei M BMC Infect Dis. 2024; 24(1):90.

PMID: 38225571 PMC: 10789054. DOI: 10.1186/s12879-023-08930-5.


New insights into the treatment of acute otitis media.

El Feghaly R, Nedved A, Katz S, Frost H Expert Rev Anti Infect Ther. 2023; 21(5):523-534.

PMID: 37097281 PMC: 10231305. DOI: 10.1080/14787210.2023.2206565.


Incidence of acute otitis media from 2003 to 2019 in children ≤ 17 years in England.

Mohanty S, Podmore B, Cunado Moral A, Weiss T, Matthews I, Sarpong E BMC Public Health. 2023; 23(1):201.

PMID: 36717794 PMC: 9885604. DOI: 10.1186/s12889-023-14982-8.